Sanofi And GSK’s Much-Delayed COVID-19 Vaccine Ready To File, But Role Looks Limited

Solid Data But No Advantages Over mRNA Jabs

 
• By Andrew McConaghie
  
GSK Sanofi
Sanofi began developing its vaccine in February 2020, and joined forces with GSK two months later, but setbacks have badly delayed its filing. • Source: Alamy

More from Clinical Trials

More from R&D